Healthcare systems worldwide are addressing polypharmacy as a major public health issue, with new guidance emphasizing person-centered medication reviews and risk mitigation strategies across multiple clinical settings including infectious disease care.
T-cell immunotherapies including CAR T-cell therapy and T-cell engagers are expanding cancer treatment options but present significant cardiovascular risks and operational complexities requiring coordinated multidisciplinary management.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07300306 |
Validation of SOFA-2 for Mortality and Sepsis-3 Prevalence in Turkey |
RECRUITING | |
| NCT07119411 |
ICU Background Early Awareness for Critical deterioratiON |
NOT_YET_RECRUITING | |
| NCT07085455 |
The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN) |
RECRUITING | NA |
| NCT07068022 |
Organ Dysfunction Score for Obstetric Patients |
RECRUITING | |
| NCT05329740 |
Glucocorticoids for Post-operative Patients With Acute Type A Aortic Dissection (The GLAD Trial) |
COMPLETED | PHASE4 |
| NCT01573806 |
Pharmacology of Exenatide in Pediatric Sepsis |
WITHDRAWN | PHASE1/PHASE2 |
| NCT00852449 |
Intraoperative Hypovolemia and Fluid Therapy |
TERMINATED | PHASE4 |
| NCT00631787 |
Evaluation of Toxicity From Stem Cell Transplant |
COMPLETED |
